• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*FX25RW
Device Problem Obstruction of Flow (2423)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 03/04/2022
Event Type  Injury  
Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.Occupation - requested, others.Pma/510(k)- k130520.(b)(4).The actual sample was not returned therefore a detailed investigation could not be performed.The provided photos were confirmed.Following results were obtained: (i) there were blood clots in the lower part of hard-shell reservoir; (ii) there were blood clots in the gas exchange module of oxygenator.Since no event such as gas transfer failure or increasing of pressure was confirmed, it was inferred that the blood clots seen in the oxygenator was formed after the procedure.Review of the manufacturing record and the product release decision control sheet of the actual sample confirmed that there were not any indications of anomaly in them.A search of the complaint file found no other similar report with the involved product code/lot# combination.Since the investigation of actual product could not be performed, the cause of occurrence could not be clarified.Our reservoir is structurally designed to stabilize the blood storage surface to make it easier to manage the blood storage surface.On the other hand, it has the characteristic that the blood in the reservoir is not easily agitated.Therefore, based on its characteristics and our past experience, as a cause of forming blood clots, it was likely that blood that was agitated with air by suction and whose coagulation factor was activated flowed into the reservoir and stayed on the blood storage surface.Then, when the blood storage surface level was lowered, the formation of blood clots was noticed.Relevant ifu reference: "adequate heparinization of the blood is required to prevent it from clotting in the system.(warnings)" "do not reduce heparin during circulation.Otherwise, blood clotting might occur.(warnings)." (b)(4).
 
Event Description
The user facility reported that post tavr valve surgery, coming off bypass 30 minutes after a clot formed in the involved capiox device reservoir.Due to the continuous bleeding, volume was given as per the requirement of cvp and the patient's hemodynamics.The clot was in the deforming chamber.The oxygenator was precautionary changed while the patient was still cannulated.Medical or surgical intervention was not required to prevent patient injury.The patient's current condition was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
stephanie handy
reg. no. 2243441
950 elkton blvd.
elkton, MD 21921
9499890491
MDR Report Key13970088
MDR Text Key288479002
Report Number9681834-2022-00054
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350701046
UDI-Public04987350701046
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 03/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCX*FX25RW
Device Lot Number210713
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/05/2022
Initial Date FDA Received03/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
Patient SexFemale
Patient Weight75 KG
-
-